Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy

• Published in: Cell biochemistry and biophysics Vol. 43; no. 1; pp. 61 - 76
• Main Authors: Sopontammarak, Somkiat, Aliharoob, Assad, Ocampo, Catherina, Arcilla, Rene A, Gupta, Mahesh P, Gupta, Madhu
• Format: Journal Article
• Language: English
• Published: United States Springer Nature B.V 01-01-2005
• Subjects: Animals; Blood Pressure; Cardiac Volume; Extracellular Signal-Regulated MAP Kinases - metabolism; Gene Expression Regulation, Enzymologic; Hypertrophy, Left Ventricular - enzymology; JNK Mitogen-Activated Protein Kinases - metabolism; Kinases; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases - metabolism; p38 Mitogen-Activated Protein Kinases - metabolism; Proteins; Rats; Rats, Sprague-Dawley; Rodents
• ISSN: 1085-9195; 1085-9195; 1559-0283
• DOI: 10.1385/cbb:43:1:061

Chronic pressure overload (PO) and volume overload (VO) result in morphologically and functionally distinct forms of myocardial hypertrophy. However, the molecular mechanism initiating these two types of hypertrophy is not yet understood. Data obtained from different cell types have indicated that the mitogen-activated protein kinases (MAPKs) comprising c-Jun NH2-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38 play an important role in transmitting signals of stress stimuli to elicit the cellular response. We tested the hypothesis that early induction of MAPKs differs in two types of overload on the heart and associates with distinct expression of hypertrophic marker genes, namely ANF, alpha-myosin heavy chain (alpha-MHC), and beta-MHC. In rats, VO was induced by aortocaval shunt and PO by constriction of the abdominal aorta. The PO animals were further divided into two groups depending on the severity of the constriction, mild (MPO) and severe pressure overload (SPO), having 35 and 85% aortic constriction, respectively. Early changes in MAPK activity (2-120 min and 1 to 2 d) were analyzed by the in vitro kinase assay using kinase-specific antibodies for p38, JNK, and ERK2. The change in expression of hypertrophy marker genes was examined by Northern blot analysis. In VO hypertrophy, the activity of p38 was markedly increased (10-fold), without changing the activity of ERK and JNK. However, during PO hypertrophy, the activity of JNK was significantly increased (two- to sixfold) and depended on the severity of the load. The activity of p38 was not changed in MPO hypertrophy, whereas it was slightly elevated (50%) in hearts with SPO. Similarly, ERK activity was not changed in hearts with MPO, but a transient rise in activity was observed in hearts with SPO. The expression of ANF and beta-MHC genes was elevated in both PO and VO hypertrophy; however, this change was much greater in hearts subjected to PO than VO hypertrophy. Alpha-MHC expression was downregulated in PO but remained unchanged in VO hypertrophy hearts. Thus, these results demonstrate differential activation of MAPKs in two types of cardiac hypertrophy and this, in part, may contribute to differential expression of cardiac muscle gene expression, giving rise to unique cardiac phenotype associated with different hemodynamic overloads.